With 1.06 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.51 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $12.265 whereas the lowest price it dropped to was $11.93. The 52-week range on EVH shows that it touched its highest point at $35.00 and its lowest point at $10.53 during that stretch. It currently has a 1-year price target of $23.38. Beta for the stock currently stands at 1.46.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EVH was up-trending over the past week, with a rise of 7.82%, but this was up by 4.26% over a month. Three-month performance dropped to -54.44% while six-month performance fell -38.71%. The stock lost -63.29% in the past year, while it has gained 6.67% so far this year. A look at the trailing 12-month EPS for EVH yields -0.91 with Next year EPS estimates of 1.11. For the next quarter, that number is 0.07. This implies an EPS growth rate of -13.04% for this year and 46.82% for next year. EPS is expected to grow by 30.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -13.43%.
Float and Shares Shorts:
At present, 115.01 million EVH shares are outstanding with a float of 112.74 million shares on hand for trading. On 2024-12-13, short shares totaled 9.76 million, which was 848.0 higher than short shares on 1731628800. In addition to Mr. Seth Barrie Blackley as the firm’s Co-Founder, CEO & Director, Mr. Dan McCarthy serves as its President.
Institutional Ownership:
Through their ownership of 1.14027 of EVH’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, EVH reported revenue of $621401000.0 and operating income of -$16068000.0. The EBITDA in the recently reported quarter was $12155000.0 and diluted EPS was -$0.27.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EVH since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With EVH analysts setting a high price target of 47.21 and a low target of 15.0, the average target price over the next 12 months is 25.515. Based on these targets, EVH could surge 293.42% to reach the target high and rise by 25.0% to reach the target low. Reaching the average price target will result in a growth of 112.62% from current levels.
Analysts have provided yearly estimates in a range of $0.97928 being high and $0.41233 being low. For EVH, this leads to a yearly average estimate of $0.61849.
